VistaGen Therapeutics Inc (VTGN) earnings · rev $1.3M
These earnings events as JSON? API free 100/dayVistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
This VTGN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported VTGN revenue for 2026-03-31 was $1.3M. Net income was -$69.7M. Revenue was up 19.3% from 2024-03-31 to 2026-03-31. VTGN currently screens at market cap $28.1M.
When the next VTGN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 19.3% from 2024-03-31 to 2026-03-31. An earnings headline that ignores that move is noise.
Not investment advice. Full VTGN research stays on the stock page; the tape stays on the quote page.
VTGN earnings FAQ
What are VTGN's latest revenue and net income?
Latest cached VistaGen Therapeutics Inc (VTGN) revenue for Mar 31, 2026 was $1.3M. Net income was -$69.7M. Statements: https://lician.com/financials/vtgn
What is VTGN's latest diluted EPS?
Latest cached VistaGen Therapeutics Inc (VTGN) diluted EPS for Mar 31, 2026 was -$1.83.
What period does the latest VTGN earnings print cover?
The latest cached VistaGen Therapeutics Inc (VTGN) earnings print covers Mar 31, 2026. The prior cached period on this page is Mar 31, 2024.
How did VTGN revenue change from the prior cached period?
Cached VistaGen Therapeutics Inc (VTGN) revenue was up 19.3% from $1.1M (Mar 31, 2024) to $1.3M (Mar 31, 2026). Statements: https://lician.com/financials/vtgn
Where are VTGN earnings listed?
Cached earnings facts for VistaGen Therapeutics Inc (VTGN) are listed at https://lician.com/earnings/vtgn. Statements: https://lician.com/financials/vtgn
Not investment advice.